MAD2L2 and malignant colon neoplasm: MAD2L2 is involved in mitosis checkpoint control; its expression is upregulated in colon cancer tissue as compared with the adjacent normal tissue, and there is excessive MAD2L2 expression in patients with colorectal cancer with poor prognosis [31].